Stefan Foser

634 total citations
18 papers, 507 citations indexed

About

Stefan Foser is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Stefan Foser has authored 18 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Stefan Foser's work include Hepatitis C virus research (5 papers), Cancer Diagnosis and Treatment (4 papers) and Cancer Genomics and Diagnostics (4 papers). Stefan Foser is often cited by papers focused on Hepatitis C virus research (5 papers), Cancer Diagnosis and Treatment (4 papers) and Cancer Genomics and Diagnostics (4 papers). Stefan Foser collaborates with scholars based in Switzerland, United States and Spain. Stefan Foser's co-authors include Ulrich Certa, K.A. Weyer, Elke Dietel, Thomas Schreitmüller, Bernd Bohrmann, Martin Ebeling, Hans Senn, Francis Müller, Alfred Ross and Clemens Broger and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Stefan Foser

17 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Foser Switzerland 11 223 144 130 99 67 18 507
Rajesh Vij United States 10 365 1.6× 104 0.7× 265 2.0× 140 1.4× 85 1.3× 13 726
Gary Li United States 13 355 1.6× 136 0.9× 197 1.5× 128 1.3× 74 1.1× 32 702
Yoichiro Tanaka Japan 13 289 1.3× 207 1.4× 65 0.5× 85 0.9× 23 0.3× 40 691
Julie Hafner United States 16 424 1.9× 232 1.6× 138 1.1× 90 0.9× 59 0.9× 16 640
Hoa Nguyen United States 9 229 1.0× 74 0.5× 124 1.0× 77 0.8× 46 0.7× 23 490
Piet J. Boender Netherlands 14 330 1.5× 65 0.5× 87 0.7× 200 2.0× 46 0.7× 24 582
Melissa Zarr United States 8 322 1.4× 324 2.3× 230 1.8× 44 0.4× 62 0.9× 8 691
Taina Jaatinen Finland 17 332 1.5× 223 1.5× 105 0.8× 20 0.2× 67 1.0× 28 750
Yanping Wang China 16 328 1.5× 192 1.3× 123 0.9× 84 0.8× 183 2.7× 32 656
Amanda McWatters United States 14 221 1.0× 112 0.8× 191 1.5× 91 0.9× 33 0.5× 27 538

Countries citing papers authored by Stefan Foser

Since Specialization
Citations

This map shows the geographic impact of Stefan Foser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Foser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Foser more than expected).

Fields of papers citing papers by Stefan Foser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Foser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Foser. The network helps show where Stefan Foser may publish in the future.

Co-authorship network of co-authors of Stefan Foser

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Foser. A scholar is included among the top collaborators of Stefan Foser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Foser. Stefan Foser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hornburg, Daniel, Torsten Mueller, & Stefan Foser. (2024). Leveraging Proteomics for Precision Cancer Research, Diagnosis, and Treatment. Genetic Engineering & Biotechnology News. 44(9). 48–50.
2.
Foser, Stefan, et al.. (2024). Looking to the Future of Early Detection in Cancer: Liquid Biopsies, Imaging, and Artificial Intelligence. Clinical Chemistry. 70(1). 27–32. 38 indexed citations
3.
Pauli, Chantal, Tilmann Bochtler, Linda Mileshkin, et al.. (2019). A challenging task – Identifying carcinoma of unknown primary (CUP) patients according to ESMO guidelines: The CUPISCO trial experience. Annals of Oncology. 30. v813–v814. 3 indexed citations
6.
Krämer, Alwin, Ferrán Losa, Laurie M. Gay, et al.. (2018). Genomic profiling of carcinomas of unknown primary (CUP) to support clinical decisions.. Journal of Clinical Oncology. 36(15_suppl). e24162–e24162. 2 indexed citations
7.
Barlési, Fabrice, Luis Paz‐Ares, Damian R. Page, et al.. (2018). P1.01-04 Treatment Patterns and Overall Survival Following Biomarker Testing in Real-World Advanced NSCLC Patients. Journal of Thoracic Oncology. 13(10). S459–S460. 1 indexed citations
8.
Shewade, Ashwini, Peter Lambert, Brandon Arnieri, et al.. (2017). Characteristics of advanced non-small cell lung cancer (aNSCLC) patients (pts) receiving molecular diagnostic (MD) testing in U.S. routine clinical practice.. Journal of Clinical Oncology. 35(15_suppl). e20627–e20627. 1 indexed citations
9.
Badiger, Rekha, Jane A. Mitchell, Stefan Foser, et al.. (2012). Effect of Different Interferonα2 Preparations on IP10 and ET-1 Release from Human Lung Cells. PLoS ONE. 7(10). e46779–e46779. 11 indexed citations
10.
Siegrist, Fredy, et al.. (2011). Interferon-Alpha Induces Reversible DNA Demethylation of the Interferon-Induced Transmembrane Protein-3 Core Promoter in Human Melanoma Cells. Journal of Interferon & Cytokine Research. 31(8). 601–608. 16 indexed citations
11.
Ebeling, Martin, et al.. (2007). Antiproliferative Activity of the Human IFN- α -Inducible Protein IFI44. Journal of Interferon & Cytokine Research. 27(8). 675–680. 84 indexed citations
12.
Foser, Stefan, et al.. (2006). Interferon-alpha and transforming growth factor-β co-induce growth inhibition of human tumor cells. Cellular and Molecular Life Sciences. 63(19-20). 2387–2396. 22 indexed citations
13.
Dhalluin, Christophe, Alfred Ross, Stefan Foser, et al.. (2005). Structural and Biophysical Characterization of the 40 kDa PEG−Interferon-α2aand Its Individual Positional Isomers. Bioconjugate Chemistry. 16(3). 504–517. 93 indexed citations
14.
Québatte, Maxime, Stefan Foser, Ulrich Certa, & Michaela Dehio. (2005). The transcriptional response of human endothelial cells to infection with Bartonella henselae is dominated by genes controlling innate immune responses, cell cycle, and vascular remodelling. Thrombosis and Haemostasis. 94(8). 347–361. 12 indexed citations
15.
Foser, Stefan, K.A. Weyer, Walter Huber, & Ulrich Certa. (2003). Improved biological and transcriptional activity of monopegylated interferon-α-2a isomers. The Pharmacogenomics Journal. 3(6). 312–319. 13 indexed citations
16.
Foser, Stefan, et al.. (2003). Isolation, structural characterization, and antiviral activity of positional isomers of monopegylated interferon α-2a (PEGASYS). Protein Expression and Purification. 30(1). 78–87. 141 indexed citations
17.
Brem, Reto, et al.. (2003). Inhibition of proliferation by 1-8U in interferon-α-responsive and non-responsive cell lines. Cellular and Molecular Life Sciences. 60(6). 1235–1248. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026